Emails reveal Hunter Biden helped fund US biolab contractor in Ukraine

An exclusive report from The National Pulse revealed that Hunter Biden's bio firm partnered with Ukrainian researchers tasked with "isolating deadly pathogens" using funds from the Obama administration's Department of Defense.

The National Pulse exclusively reported Thursday that an investment firm directed by President Joe Biden's controversial son Hunter Biden was "a leading financial backer of a pandemic tracking and response firm that collaborated on identifying and isolating deadly pathogens in Ukrainian laboratories," while receiving funds from President Barack Obama's Defense Department in the process.

Emails from Hunter Biden's abandoned laptop show he "helped secure millions of dollars of funding for Metabiota, a Department of Defense contractor specializing in research on pandemic-causing diseases that could be used as bioweapons," according to new communications also obtained by DailyMail.com.

Rosemont Seneca Technology Partners (RSTP), a subsidiary of the Hunter Biden-founded Rosemont Capital, listed the US president's son as a managing director.

Amongst the companies listed on archived versions of the RSTP's investment portfolio is San Francisco-based Metabiota, which purports to detect, track, and analyze emerging infectious diseases, The National Pulse explained.

Metabiota says it is dedicated to the discovery and prevention of new infectious pathogens. "Metabiota has over a decade of experience partnering with industry and governments worldwide to build resilience to epidemics and protect global public health," according to the description on the company's website.

But what Hunter Biden likely saw as an investment opportunity to invest in an up-and-coming medical research entity may have been interpreted by Russia as a threat—one of the many justifications the Kremlin has given for its "special military operation" in Ukraine. Russia recently hinted at a potential threat coming from a partnership between the United States and Ukraine researchers, claiming international cooperation to develop a biological weapon. Meanwhile, it's an accusation that's been largely dismissed by the international community.

In response to the allegations, the United Nations released a statement on March 18, saying that it could find no reason to believe that this was in fact the case. At the UN’s Security Council, UN Undersecretary Izumi Nakamitsu stated that the accusations were unfounded and amounted to nothing more than theatre.

On top of the UN's assertions, the United States Department of State issued a press release on March 14, stating that "The Kremlin's false allegations of U.S. labs and chemical, biological, radiological, and nuclear (CBRN) threats in Ukraine are the latest examples of disinformation we have repeatedly debunked over the years in Ukraine and around the world." Russia, and the Soviet Union, "has long accused the West of the very CBRN actions it undertakes," the State Department said.

But back at the UN's security council, the Russian Federation's representative asserted that Russia had recovered evidence that the United States had been conducting joint biological research in Ukraine and had funded those efforts to the tune of $32 million. Moreover, the representative also presented documentation to back up the claim. According to the UN's press release, the US representative couldn’t produce a ready explanation on March 11, when confronted:

"The delegate of the United States was not able to explain documented proof of a 2005 agreement signed between the United States and Ukrainian ministers, which laid out support for joint biological research on Ukrainian territory."

And that's where Hunter Biden seemingly comes into play.

While the date of the reported funding came 10 years after the period in which Russia claimed the funds were first agreed upon, there's now a connection between the Biden-linked pandemic firm and Ukraine-based biological laboratories.

Government spending records show that the Department of Defense agreed to invest a base amount of $18.4 million in 2014 via an awarded contract to Metabiota between February of that year and November 2016. The company would receive these payments over time, with $307,091 earmarked for "Ukraine research projects," both the Daily Mail and The National Pulse reported.